Education
About Us
Working with TipRanks
Follow Us
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
Dividend Data
Last Ex-Dividend Date
Sep 19, 2025Payment date
Oct 25, 2025
Oct 25, 2025
Dividend Amount Per Share
₹1Notavailable
Dividend Yield
0.26%Sector: Healthcare
Sector Average: 1.658%
Sector Average: 1.658%
Payout Ratio
13.54%Dividend Growth
3 years Since 2022
Last 3 Months
MEDICAMEQ Dividend History
Ex-Date | Record Date | Payment Date | Frequency | Declaration Date | Amount |
|---|---|---|---|---|---|
Sep 19, 2025 | Sep 19, 2025 | Oct 25, 2025 | Not Available | ― | ₹1.00 |
Sep 19, 2024 | Sep 19, 2024 | Oct 26, 2024 | Annually | ― | ₹1.00 |
Sep 20, 2023 | Sep 20, 2023 | Oct 27, 2023 | Annually | ― | ₹1.00 |
Sep 19, 2022 | Sep 20, 2022 | Oct 27, 2022 | Annually | ― | ₹1.00 |
FAQ
Does Medicamen Biotech Limited pay dividends?
Yes, IN:MEDICAMEQ has paid a dividend within the past 12 months.
How much is Medicamen Biotech Limited's dividend?
IN:MEDICAMEQ pays a dividend of ₹1 per share. IN:MEDICAMEQ's annual dividend yield is 0.26%.
When is Medicamen Biotech Limited ex-dividend date?
Medicamen Biotech Limited's previous ex-dividend date was on Sep 19, 2025. Medicamen Biotech Limited shareholders who own IN:MEDICAMEQ stock before this date received Medicamen Biotech Limited's last dividend payment of ₹1 per share on Oct 25, 2025. IN:MEDICAMEQ's next ex-dividend date has not been announced yet.
When is Medicamen Biotech Limited dividend payment date?
Medicamen Biotech Limited’s next quarterly payment date is on Oct 25, 2025, when Medicamen Biotech Limited shareholders who owned IN:MEDICAMEQ shares before Sep 19, 2025 received a dividend payment of ₹1 per share. Add IN:MEDICAMEQ to your watchlist to be reminded of IN:MEDICAMEQ's next dividend payment.
Does Medicamen Biotech Limited have sufficient earnings to cover their dividend?
Yes, IN:MEDICAMEQ's past year earnings per share was ₹1.59, and their annual dividend per share is ₹1.00. IN:MEDICAMEQ's dividend payout ratio is 13.54% (₹1.00/₹1.59) which is sustainable.